Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta‐analysis of randomized clinical trials.
- Published in:
- Obesity Reviews, 2024, v. 25, n. 6, p. 1, doi. 10.1111/obr.13725
- By:
- Publication type:
- Article
Works by Jiao, Ruoyang
Results: 7
1
2
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 806, doi. 10.1111/dom.16078
- By:
- Publication type:
- Article
3
Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis.
- Published in:
- 2025
- By:
- Publication type:
- Literature Review
4
Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross‐sectional data.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, p. 5, doi. 10.1111/dom.15029
- By:
- Publication type:
- Article
5
Evaluation of efficacy and safety of glucokinase activators--a systematic review and meta-analysis.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1175198
- By:
- Publication type:
- Article
6
The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
- Published in:
- Expert Opinion on Pharmacotherapy, 2023, v. 24, n. 4, p. 511, doi. 10.1080/14656566.2023.2181693
- By:
- Publication type:
- Article
7
The association between the eGFR slope and cardiorenal prognosis in patients with renoprotective treatments: A systematic review and meta‐analysis.
- Published in:
- Journal of Evidence-Based Medicine, 2024, v. 17, n. 3, p. 643, doi. 10.1111/jebm.12646
- By:
- Publication type:
- Article